Following the protocol described in Section 4, mosaic organoids containing H2B-mCherry- and H2B-iRFP-labeled cell populations form within 48 h of seeding. Successful mosaic formation is characterized by either a salt-and-pepper distribution or defined boundaries between the two populations, depending on the degree of dissociation used. A salt-and-pepper distribution refers to a random, single-cell intermixing of the two populations, in which cells of each population are interspersed at the single-cell level, with no large clonal domains. Defined boundaries, by contrast, result in coherent patches of each cell population within the same organoid. The degree of cell dispersal is controlled by the duration of the dissociation step and the vigor of pipetting: thorough single-cell dissociation produces salt-and-pepper mosaics, while gentle fragmentation preserves small clonal clusters (Figure 3A).
The mosaic labeling enables single-cell analysis of processes that cannot be resolved in uniformly labeled tissues. When an individual cell co-expressing a reporter of interest (e.g., a fluorescent Myosin-II reporter) is surrounded by unlabeled neighbors, its cytoskeletal dynamics during migration, division, or extrusion can be unambiguously attributed to that cell (Figure 3B). Nuclear H2B reporters facilitate the identification of informative cell constellations within the mosaic, and per-cell measurements, such as lifetime, division rate, and reporter intensity dynamics, can be extracted from the tracking data (Figure 3C). When two genotypes are mixed, these per-cell metrics can be compared across populations to assess competitive fitness differences.
In human intestinal organoids carrying the MUC2-mNeonGreen and DEFA5-dsRed fate reporters, secretory cell fate commitment is evident as a gradual increase in reporter fluorescence over days. Organoids cultured in Maturation Medium were transferred to glass-bottom plates on day 7 and imaged by confocal live-cell microscopy (Figure 4A). Time-lapse imaging reveals two distinct reporter dynamics: goblet cells activate and maintain high MUC2-mNeonGreen expression throughout the imaging period, while Paneth cells display initial MUC2-mNeonGreen activation followed by progressive signal decrease and subsequent DEFA5-dsRed activation6 (Figure 4A). Single-cell quantification confirms this sequential transition at the level of individual cells (Figure 4B), suggesting that Paneth cell commitment proceeds through a transient MUC2-expressing intermediate state rather than directly from an unlabeled progenitor. Averaged intensity curves across multiple tracked cells confirm that this pattern is consistent at the population level, with Paneth cell precursors displaying a characteristic inverse relationship between MUC2-mNeonGreen and DEFA5-dsRed signals (Figure 4C). Together, these data demonstrate that the dual reporter system resolves distinct secretory fate trajectories at single-cell resolution.

Figure 1: The workflow that integrates confocal live-cell imaging and single-cell tracking with two complementary reporter strategies in human and murine intestinal organoids. (A) Schematic overview of the mosaic organoid generation workflow. Murine intestinal organoids expressing H2B-mCherry (magenta) or H2B-iRFP (green) are dissociated into single cells, mixed at defined ratios, and seeded onto a BME-coated plate for 24 h aggregate formation before re-embedding in BME. (B) Schematic overview of human intestinal organoids differentiation. Human organoids expressing MUC2-mNeonGreen (goblet cells, green) and DEFA5-dsRed (Paneth cells, magenta) endogenous knock-in reporters are differentiated using a two-step protocol. Organoids are first cultured in Patterning Medium for 14 days, followed by Maturation Medium for 7–10 days. During differentiation, organoids transition from a cystic, spherical morphology to an extensively budded structure that harbors major intestinal cell types, including MUC2-mNeonGreen-positive goblet cells and DEFA5-dsRed-positive Paneth cells. (C) 3D time-lapse confocal imaging of a murine mosaic intestinal organoid expressing nuclear reporters. (D) Single-cell tracking and lineage reconstruction using a semi-automated organoid cell-tracking software tool. Detected nuclei are linked across time points to reconstruct cell trajectories and lineage trees, enabling quantification of cell division, migration, and extrusion events. Please click here to view a larger version of this figure.

Figure 2: Comparison of healthy and phototoxic human intestinal organoids during live confocal imaging. (A) Representative brightfield and fluorescence images of a healthy human intestinal organoid. Healthy organoids display clear cystic or budding morphology with no cell debris in the surrounding medium. (B) Representative brightfield and fluorescence images of a human intestinal organoid showing phototoxic damage. Signs of phototoxicity include accumulation of cell debris in the surrounding medium, nuclear condensation, and arrested cell division. H2B-mCherry fluorescence images are shown as maximum intensity projections. Scale bars, 100 µm. Please click here to view a larger version of this figure.

Figure 3: Mosaic organoid generation and single-cell resolution of cytoskeletal dynamics in murine intestinal organoids. (A) Schematic of mosaic organoid generation by dissociation, mixing at defined ratios, and re-aggregation. Representative confocal images of mosaic organoids generated at cell ratios of 1:9, 1:5, and 1:2 (H2B-mCherry, green; H2B-iRFP, magenta) using single-cell dissociation (top row) or small-fragment dissociation (bottom row). Single-cell dissociation produces a salt-and-pepper mixing pattern, while small-fragment dissociation results in larger clonal patches. Scale bars, 50 µm. (B) Confocal images of mosaic organoids in which a dense (left) or sparse (right) population expresses Myosin-II-mNeonGreen (green), while the other population expresses only H2B-iRFP (magenta). Dashed boxes indicate the regions magnified in (C). Scale bars, 20 µm. (C) Time-lapse series showing cell extrusion at 8 min intervals, aligned to the moment of cell removal (t = 0 min). Top row (arrowheads): extrusion of a unlabeled cell surrounded by Myosin-II-mNeonGreen-expressing neighbors, revealing the neighborhood response. Bottom row (asterisks): extrusion of an individual Myosin-II-mNeonGreen-expressing cell surrounded by unlabeled neighbors, enabling unambiguous attribution of cortical myosin dynamics to the extruding cell. Scale bars, 10 µm. Right: normalized Myosin-II-mNeonGreen fluorescence intensity over time for extruding cells, aligned to the moment of cell removal (t = 0 min). Myosin-II accumulates progressively in the minutes preceding extrusion, peaking at the time of removal. Shaded area indicates standard deviation. Please click here to view a larger version of this figure.

Figure 4: Real-time monitoring of secretory cell fate transitions in human intestinal organoids using MUC2-mNeonGreen and DEFA5-dsRed fate reporters. Please click here to view a larger version of this figure.
(A) Representative time-lapse confocal images of a human intestinal organoid cultured in Maturation Medium and imaged from day 7 of maturation. MUC2-mNeonGreen (green) marks goblet cells and DEFA5-dsRed (magenta) marks Paneth cells. Scale bar, 20 µm. (B) Single-cell quantification of MUC2-mNeonGreen (green) and DEFA5-dsRed (magenta) fluorescence intensity over time for a representative Paneth cell, showing initial MUC2-mNeonGreen activation followed by progressive signal decrease and subsequent DEFA5-dsRed onset. Fluorescence intensity is shown in arbitrary units (a.u.). (C) Averaged fluorescence intensity curves for goblet cells (n = 7 cells) and Paneth cell precursors (n = 8 cells) showing MUC2-mNeonGreen (green) and DEFA5-dsRed (magenta) signal dynamics over time6. For Paneth cell precursors, time is aligned to the first appearance of DEFA5-dsRed signal (t = 0 h). Goblet cells maintain consistently high MUC2-mNeonGreen intensity over time, while Paneth cell precursors display a characteristic inverse relationship between MUC2-mNeonGreen and DEFA5-dsRed signals. Shaded areas indicate standard deviation.
| Component | Stock concentration | Final concentration |
| Advanced Dulbecco's Modified Eagle Medium/F12 (Advanced DMEM/F12) | | Base medium |
| HEPES | 1M | 10mM |
| Glutamax | 200mM | 2mM |
| N2 supplement | 100x | 1x |
| B27 supplement | 50x | 1x |
| N-acetylcysteine | 500mM | 1mM |
| Penicillin/Streptomycin | 10000U/ml, 10000ug/ml | 100U/ml, 100ug/ml |
| Recombinant murine EGF | | 50ng/ml |
| Recombinant murine Noggin | | 100ng/ml |
| Recombinant human R-spondin 1 | | 500ng/ml |
Table 1: Growth medium for murine intestinal organoids.
| Component | Stock concentration | Final concentration |
| Advanced Dulbecco's Modified Eagle Medium/F12 (Advanced DMEM/F12) | | Base medium |
| HEPES | 1M | 10mM |
| Glutamax | 200mM | 2mM |
| B27 supplement | 50x | 1x |
| Penicillin/Streptomycin | 10000U/ml, 10000ug/ml | 100U/ml, 100ug/ml |
| Primocin | 50mg/ml | 100ug/ml |
| R-spondin conditioned medium (U-Protein Express) | | 2% |
| Noggin conditioned medium (U-Protein Express) | | 2% |
| N-acetylcysteine | 500mM | 1mM |
| Nicotinamide | 1M | 10mM |
| Human recombinant EGF | 500ug/ml | 50ng/ml |
| A83-01 | 5mM | 500nM |
| SB202190 (p38 inhibitor) | 30mM | 3uM |
| Prostaglandin E2 | 10mM | 1uM |
| Wnt surrogate | | 1000x |
Table 2: Expansion medium for human intestinal organoids.
| Component | Stock concentration | Final concentration |
| Advanced Dulbecco's Modified Eagle Medium/F12 (Advanced DMEM/F12) | | Base medium |
| HEPES | 1M | 10mM |
| Glutamax | 200mM | 2mM |
| B27 supplement | 50x | 1x |
| Penicillin/Streptomycin | 10000U/ml, 10000ug/ml | 100U/ml, 100ug/ml |
| Primocin | 50mg/ml | 100ug/ml |
| R-spondin conditioned medium (U-Protein Express) | | 2% |
| Noggin conditioned medium (U-Protein Express) | | 2% |
| N-acetylcysteine | 500mM | 1mM |
| Human recombinant EGF | 500ug/ml | 50ng/ml |
| A83-01 | 5mM | 500nM |
| Wnt surrogate | | 1000x |
| CHIR99021 | 3mM | 3uM |
| Recombinant Human IL-22 | 10 ug/ml | 2ng/ml |
Table 3: Patterning medium for human intestinal organoids.
| Component | Stock concentration | Final concentration |
| Advanced Dulbecco's Modified Eagle Medium/F12 (Advanced DMEM/F12) | | Base medium |
| HEPES | 1M | 10mM |
| Glutamax | 200mM | 2mM |
| B27 supplement | 50x | 1x |
| Penicillin/Streptomycin | 10000U/ml, 10000U/ml | 100U/ml, 100U/ml |
| Primocin | 50mg/ml | 100ug/ml |
| R-spondin conditioned medium (U-Protein Express) | | 2% |
| Noggin conditioned medium (U-Protein Express) | | 2% |
| N-acetylcysteine | 500mM | 1mM |
| Human recombinant EGF | 500ug/ml | 50ng/ml |
| A83-01 | 5mM | 500nM |
| Wnt surrogate | | 30000x |
| Recombinant Human IL-22 | 10 ug/ml | 2ng/ml |
Table 4: Maturation medium for human intestinal organoids.